● Covered by 1 source · 1 reportMedium impact1 neutral
AI Agent Autonomously Performs Brain Surgery on Mouse, Selecting Treatment and Target
Key points
- AI agent chose gene therapy, dosage, and brain target for mouse surgery.
- Anthropic Sonnet model controlled robotic injection into the mouse brain.
- A veterinarian oversaw the procedure, approving irreversible steps.
- Previous Anthropic models (Opus 5.5, Opus 5) refused live surgery.
AI Agent Conducts Autonomous Brain Surgery
Exin Therapeutics, a biotech startup, reports that an AI agent successfully performed brain surgery on a mouse. The co-founder and CEO, Gabriel Ocana-Santero, shared details of the procedure, highlighting the AI's role in selecting treatment parameters and executing the surgery.
AI's Role in Treatment Selection and Delivery
The AI agent autonomously determined the appropriate gene therapy vector, its dosage, and the specific brain region for application. It then operated robotic arms to inject the medication into the mouse's brain. This differs from existing surgical robots where humans decide the operation, and the robot only executes it.
Technology Used and Safety Measures
The team utilized Anthropic Sonnet, providing it with a mouse epilepsy model, control of a motorized surgery rig, a list of 19 gene therapy vectors, and three research papers. A licensed veterinarian supervised the entire operation, requiring approval for every irreversible step. The system also included an emergency stop button. The AI was not permitted to perform the craniotomy, which was done by the vet.
Model Selection Challenges
Interestingly, Exin Therapeutics used Anthropic's mid-range Sonnet model. Earlier attempts with Opus 5.5 failed as it refused to work on a biological experiment. The older Opus 5 model could plan the procedure on paper but declined to perform live surgery, indicating varying ethical or safety guardrails across different AI models.
Implications for AI in Medicine
This experiment demonstrates an AI agent's capability to move beyond execution to autonomous decision-making in a complex biological context. While conducted under strict human supervision and with safety protocols, it suggests future possibilities for AI in therapeutic development and surgical applications, where AI could potentially identify and deliver treatments independently.
✨ This summary was generated by AI from the outlets' reporting listed below. It is not independently verified and may contain errors — check the original sources. How BrevFeed works →
The daily brief
One email each morning: the day's tech stories, clustered across outlets and summarized. No account needed.
One email a day. Unsubscribe in one click, any time.
Today's brief
Spend a few minutes, get the whole day. Every topic's top stories in one hands-free rundown — listen, watch, or read the transcript.
▶ Play today's brief
New every morning, and the back catalogue is archived by date.
Reporting from
Exin Therapeutics claims to have successfully performed brain surgery on a mouse using an Anthropic Sonnet AI agent. The AI agent autonomously selected the gene therapy vector, dosage, and brain region for application, then controlled robotic arms to inject the medication. This marks a step towards AI agents independently determining and executing complex biological procedures, though human oversight and safety protocols were in place.